SCHEMBL7325830

SCHEMBL7325830

COC(=O)[C@H](Cc1ccc(OCC(=O)O)cc1)NC(=O)[C@@H]1CCCN1S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 2/20 0.57
ITGB1 P05556 4/20 0.52
ITGA5 P08648 3/20 0.52
RGS12 O14924 1/20 0.51
KMT2A Q03164 1/20 0.49
FKBP1A P62942 2/20 0.49
MMP1 P03956 1/20 0.48
ADAM17 P78536 1/20 0.48
HCRTR1 O43613 3/20 0.48
HCRTR2 O43614 3/20 0.48
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
CYP3A4 P08684 1/20 0.48
ITGAV P06756 1/20 0.48
ITGB7 P26010 1/20 0.48
KCNQ1 P51787 2/20 0.47
RAB9A P51151 1/20 0.47
GAA P10253 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7446444 0.98 ITGA4 (0.61) ITGA4ITGB1ITGA5RGS12KMT2A
SCHEMBL7323451 0.93 ITGA4 (0.63) ITGA4ITGB1ITGA5RGS12KMT2A
SCHEMBL7325073 0.92 ITGA4 (0.56) ITGA4ITGB1ITGA5KMT2AFKBP1A
SCHEMBL7361018 0.90 ITGA4 (0.55) ITGA4ITGB1ITGA5FKBP1AMMP1
SCHEMBL6709270 0.90 ITGA4 (0.60) ITGA4ITGB1ITGA5FKBP1AHCRTR1
SCHEMBL6710599 0.90 ITGA4 (0.54) ITGA4ITGB1ITGA5KMT2AFKBP1A
SCHEMBL7348048 0.89 ITGB1 (0.53) ITGA4ITGB1ITGA5KMT2AFKBP1A
SCHEMBL7508673 0.88 ITGA4 (0.58) ITGA4ITGB1ITGA5FKBP1AMMP1
SCHEMBL3849601 0.88 ITGA4 (0.60) ITGA4ITGB1ITGA5KMT2AFKBP1A
SCHEMBL7319551 0.87 ITGA4 (0.62) ITGA4ITGB1ITGA5KMT2AFKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP claimed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO claimed
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US disclosed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP disclosed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed